Literature DB >> 17624834

Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection.

Pierre-Yves Bochud1, Amalia S Magaret, David M Koelle, Alan Aderem, Anna Wald.   

Abstract

Clinical and virologic manifestations of genital herpes simplex virus type 2 (HSV-2) infection vary widely. We examined frequencies of single-nucleotide polymorphisms (SNPs) in Toll-like receptors (TLRs) 2, 3, 4, and 9 in a prospective cohort of 128 HSV-2-infected persons whose viral shedding and lesion frequency was measured by daily sampling from genital secretions. Two TLR2 haplotypes (2 and 4) were associated with increased lesional (P=.008 and P=.03) and shedding (P=.02 and P=.001) rates. An SNP in haplotype 2 (-15607A/G) was also associated with shedding (P=.01) and lesional (P=.008) rates. Polymorphisms in TLR2 may be in part responsible for differences in the severity of HSV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624834     DOI: 10.1086/519693

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

Review 2.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 3.  Recognition of herpesviruses by the innate immune system.

Authors:  Søren R Paludan; Andrew G Bowie; Kristy A Horan; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 4.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

5.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

Review 6.  Herpesviral infection and Toll-like receptor 2.

Authors:  Ming-sheng Cai; Mei-li Li; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-08-04       Impact factor: 14.870

7.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

8.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

9.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  Herpes simplex virus US3 tegument protein inhibits Toll-like receptor 2 signaling at or before TRAF6 ubiquitination.

Authors:  Jayita Sen; Xueqiao Liu; Richard Roller; David M Knipe
Journal:  Virology       Date:  2013-03-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.